Brucellosis diagnostic criteria: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 7: Line 7:


==Diagnostic Criteria==
==Diagnostic Criteria==
 
{| class="wikitable"
=== '''Clinical Description'''<ref name="e">Brucellosis 2010 Case Definition. CDC. http://wwwn.cdc.gov/nndss/conditions/brucellosis/case-definition/2010/. Accessed on February 2, 2016</ref> ===
! colspan="2" |Diagnosis of brucellosis
*An illness characterized by acute or insidious onset of [[fever]] and one or more of the following:  
|-
**[[Night sweats]]
|History of potential exposure
**[[Arthralgia]]
|
**[[Headache]]
|-
**[[Fatigue]]
|presentation consistent with the disease
**[[Anorexia]]
|An illness characterized by acute or insidious onset of [[fever]] and one or more of the following:
**[[Myalgia]]
*[[Night sweats]]
**[[Weight loss]]
*[[Arthralgia]]
**[[Arthritis]]/[[spondylitis]]
*[[Headache]]
**[[Meningitis]]
*[[Fatigue]]
**Focal organ involvement ([[endocarditis]], [[orchitis]]/[[epididymitis]], [[hepatomegaly]], [[splenomegaly]])
*[[Anorexia]]
 
*[[Myalgia]]
=== '''Laboratory Criteria for Diagnosis''' ===
*[[Weight loss]]
*[[Arthritis]]/[[spondylitis]]
*[[Meningitis]]
*Focal organ involvement ([[endocarditis]], [[orchitis]]/[[epididymitis]], [[hepatomegaly]], [[splenomegaly]])
|-
|Supporting laboratory findings
|
*'''Definitive:'''
*'''Definitive:'''
**Culture and identification of [[Brucella|''Brucella spp'']]. from clinical specimens
**Culture and identification of [[Brucella|''Brucella spp'']]. from clinical specimens
Line 28: Line 34:
**[[Brucella|''Brucella'']] total antibody titer of greater than or equal to 160 by standard tube agglutination test (SAT) or [[Brucella|''Brucella'']] microagglutination test (BMAT) in one or more serum specimens obtained after onset of symptoms
**[[Brucella|''Brucella'']] total antibody titer of greater than or equal to 160 by standard tube agglutination test (SAT) or [[Brucella|''Brucella'']] microagglutination test (BMAT) in one or more serum specimens obtained after onset of symptoms
**Detection of [[Brucella|''Brucella'']] DNA in a clinical specimen by PCR assay
**Detection of [[Brucella|''Brucella'']] DNA in a clinical specimen by PCR assay
|} 
**


== '''Case Classification''' ==
== '''Case Classification''' ==

Revision as of 21:16, 4 January 2017

Brucellosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Brucellosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Principles of diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X-Ray

CT Scan

MRI

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Brucellosis diagnostic criteria On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Brucellosis diagnostic criteria

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Brucellosis diagnostic criteria

CDC on Brucellosis diagnostic criteria

Brucellosis diagnostic criteria in the news

Blogs on Brucellosis diagnostic criteria

Directions to Hospitals Treating Brucellosis

Risk calculators and risk factors for Brucellosis diagnostic criteria

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Danitza Lukac

Overview

The diagnosis of brucellosis is based on clinical and laboratory criteria.[1]

Diagnostic Criteria

Diagnosis of brucellosis
History of potential exposure
presentation consistent with the disease An illness characterized by acute or insidious onset of fever and one or more of the following:
Supporting laboratory findings
  • Definitive:
    • Culture and identification of Brucella spp. from clinical specimens
    • Evidence of a fourfold or greater rise in Brucella antibody titer between acute- and convalescent-phase serum specimens obtained greater than or equal to 2 weeks apart
  • Presumptive:
    • Brucella total antibody titer of greater than or equal to 160 by standard tube agglutination test (SAT) or Brucella microagglutination test (BMAT) in one or more serum specimens obtained after onset of symptoms
    • Detection of Brucella DNA in a clinical specimen by PCR assay

Case Classification

Probable

  • A clinically compatible illness with at least one of the following:
    • Epidemiologically linked to a confirmed human or animal brucellosis case
    • Presumptive laboratory evidence, but without definitive laboratory evidence, of Brucella infection

Confirmed

  • A clinically compatible illness with definitive laboratory evidence of Brucella infection

Reference

  1. Brucellosis 2010 Case Definition. CDC. http://wwwn.cdc.gov/nndss/conditions/brucellosis/case-definition/2010/. Accessed on February 2, 2016